KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Shares Outstanding (2016 - 2025)

TherapeuticsMD's Shares Outstanding history spans 16 years, with the latest figure at $11.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.36% year-over-year to $11.6 million; the TTM value through Dec 2025 reached $11.6 million, changed 0.36%, while the annual FY2025 figure was $11.6 million, 0.36% changed from the prior year.
  • Shares Outstanding reached $11.6 million in Q4 2025 per TXMD's latest filing, roughly flat from $11.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $11.6 million in Q1 2025 to a low of $7.9 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $10.2 million, with a median of $10.6 million recorded in 2023.
  • The largest YoY upside for Shares Outstanding was 43.4% in 2021 against a maximum downside of 97.11% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $8.6 million in 2021, then rose by 10.48% to $9.5 million in 2022, then increased by 21.42% to $11.5 million in 2023, then changed by 0.0% to $11.5 million in 2024, then increased by 0.36% to $11.6 million in 2025.
  • Per Business Quant, the three most recent readings for TXMD's Shares Outstanding are $11.6 million (Q4 2025), $11.6 million (Q3 2025), and $11.6 million (Q2 2025).